Kodein Fmk

Codeine phosphate, the active ingredient in Kodein Fmk, is an opioid analgesic presented as an oral formulation for oral use. It provides pain relief and cough suppression in adults when prescribed by a healthcare professional. GNH USA supplies Kodein Fmk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kodein Fmk, an opioid analgesic, is employed in conditions where pain or cough require central suppression.

Pain relief: alleviates mild to moderate acute or chronic pain when non‑opioid options are insufficient. Cough suppression: reduces the cough reflex in respiratory infections or irritative coughs. Post‑operative discomfort: helps manage discomfort following minor surgical procedures.

Codeine phosphate may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea - Constipation - Drowsiness - Dizziness - Vomiting - Dry mouth

Serious or Rare Side Effects: - Respiratory depression - Severe allergic reactions (e.g., rash, angioedema) - Hypotension - Dependence or abuse potential - Seizures - Paralytic ileus

When prescribing or dispensing Kodein Fmk, consider the following safety measures.

Assess pain severity: ensure opioid therapy is appropriate for the level of pain. Evaluate respiratory function: avoid use in patients with compromised breathing. Review concomitant CNS depressants: monitor for additive sedation. Monitor for signs of dependence: educate patients on proper use. Adjust dose in hepatic impairment: consider reduced dosing. Store at ambient temperature: keep in original container, protect from moisture.

Codeine phosphate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - CNS depressants (e.g., benzodiazepines, barbiturates) - Alcohol consumption - Monoamine oxidase inhibitors (MAOIs)

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, quinidine) - Anticholinergic agents (e.g., diphenhydramine)